As the number of Americans living with Alzheimer’s disease is expected to triple by 2050, the sense of urgency for researchers to find better treatments and, ultimately, a cure for the 6 million people whose memories and lives are at stake has intensified.
Think Bioscience welcomes new investor YK Bioventures and drug discovery veteran Wendy Young to the board BOULDER, Colo., May 7, 2024 /PRNewswire/ — Think Bioscience (“Think”), a Boulder-based synthetic biology company focused on developing small-molecule […]
SAN FRANCISCO–(BUSINESS WIRE)– #aging–Revel Pharmaceuticals today announced a study published by its scientists as well as researchers at Calico and the University of Colorado Anschutz Medical Campus, in Nature Communications. The paper describes CMLase, an […]
Researchers from the University of Colorado Anschutz Medical Campus and Washington University in St. Louis have identified a way to assess brain activity in sleep that occurs in the earliest stages of Alzheimer’s disease, typically […]
Copyright © 2026 Biotech Networks
